David W Hagedorn

Title: Innovations by David W. Hagedorn: Pioneering Neurostimulation Technologies

Introduction: David W. Hagedorn is a notable inventor based in Jacksonville, NC, with an impressive portfolio comprising 18 patents. His work primarily focuses on advanced neurostimulation and neuromodulation technologies, which aim to enhance therapeutic outcomes for patients dealing with various brain maladies.

Latest Patents: Among his latest inventions are two significant patents for a transcranial stimulation device and method based on electrophysiological testing. The first patent outlines a neuromodulation therapy that involves receiving multiple input data points related to a patient, including brain and body value measurements. The system analyzes this input data against reference data generated through machine learning, allowing for the electronic determination of brain maladies and their severity. Consequently, it generates a customized treatment protocol, incorporating specific transcranial stimulation parameters to facilitate patient care.

The second patent emphasizes the clinical application of neurostimulation and/or neuromodulation, highlighting the importance of processing patient data relative to established data sets. This method includes the delivery of tailored treatment protocols to patients, utilizing neuromodulation and biofeedback. It emphasizes iterative assessments to refine the goodness of fit for ongoing treatments, ensuring effective patient management.

Career Highlights: David W. Hagedorn has collaborated with companies recognized for their contributions to neurotechnology, including Evoke Neuroscience, Inc. and Dj Technologies, Inc. His role in these organizations has enabled him to advance his innovative concepts into practical applications, helping reshape the field of neuromodulation therapy.

Collaborations: Throughout his career, Hagedorn has worked alongside notable colleagues, including James W. G Thompson. Their collaboration has likely driven significant advancements in the development of neurostimulation devices and methodologies, further expanding the horizons of therapeutic possibilities.

Conclusion: David W. Hagedorn's contributions to neurostimulation technology reflect a dedication to improving patient outcomes through innovation. With 18 patents to his name, his latest developments in transcranial stimulation exemplify the intersection of technology and healthcare, paving the way for future advancements in neuromodulation therapies. His work continues to inspire new research and innovation in the field, emphasizing the critical role of inventors in shaping medical solutions.